French President Emmanuel Macron, VicePresident Vo Thi Anh Xuan and senior leaders of the two countries pressed the button to start construction of the factory, within the framework of a state visit to Vietnam on May 25-27.
Mr. Ngo Chi Dung, Chairman of the Board of Directors and General Director of VNVC Vaccine Company, said that the large-capacity vaccine factory will help reduce costs, proactively supply domestically, export and be ready to participate in the global vaccine supply chain, contributing to health security in Vietnam and the region.
Mr. Burak Pekmezci, General Director of Sanofi Vietnam, expects that the VNVC Vaccine and Biological Factory, which meets global standards, will soon provide vaccines, medicines and disease prevention solutions for the Vietnamese people. "This will be a breakthrough project, contributing to the mission of protecting people's health better and better," he said.
Expected to be operational by the end of 2027, the VNVC Vaccine and Biological Products Factory will gradually receive technology transfer from Sanofi (France) to prioritize "localization" of production of important vaccines and new technology vaccines of Sanofi.
To achieve the above goals, the factory has many sub-areas including research and development sub-area, animal laboratory, vaccine and biological product production lines in many different technologies. Initially, there are three filling and packaging lines, including modern isolator technology and injection pen filling line.
The project meets the highest standards of European Good Manufacturing Practice (EU GMP), US FDA GMP and World Health Organization WHO GMP. At the same time, it strictly complies with Good Laboratory Practice (GLP) and international standards (AAALAC) on safety, welfare and humane treatment for experimental animal research areas, along with many other high standards on environmental protection, emission reduction...
The entire project prioritizes the use of environmentally friendly materials, such as recycled concrete and paints that do not contain volatile organic compounds (VOCs), making the most of natural light, solar energy and rainwater collection and reuse technology for irrigation and cooling. The insulation system helps save energy, combined with a wastewater treatment system that meets environmental standards.
The production lines can be flexibly converted to meet the needs of mass or concentrated vaccine production, suitable when there is an urgent need to prevent new pandemics.
VNVC also invested in building a 1,500 m2 Research and Development (R&D) Center, specializing in researching and applying advanced vaccine and biological production technologies, especially mRNA vaccines. The Center plans to cooperate with experts, universities, and pharmaceutical companies to conduct preclinical and clinical trials right in Vietnam. Thanks to that, people have the opportunity to access early drugs, vaccines, and new inventions, shortening the time for licensing registration.
VNVC Vaccine Company owns the VNVC Vaccination System, launched in 2017 with more than 220 centers nationwide. The unit supplies more than 50 types of vaccines, helping to prevent nearly 50 infectious diseases, including new vaccines that are often scarce on the market. Many important vaccines deployed by the unit in Vietnam such as dengue fever, meningococcal B... contribute to protecting the health of millions of people.
TH (according to VnExpress)Source: https://baohaiduong.vn/vnvc-khoi-cong-nha-may-san-xuat-vaccine-2-000-ty-dong-412573.html
![[Photo] Vice President Vo Thi Anh Xuan, French President Emmanuel Macron and his wife visit Hanoi University of Science and Technology](https://vphoto.vietnam.vn/thumb/1200x675/vietnam/resource/IMAGE/2025/5/27/267b6f2bdf3e46439f081b49f6ec26b1)
![[Photo] Hungarian President begins official visit to Vietnam](https://vphoto.vietnam.vn/thumb/1200x675/vietnam/resource/IMAGE/2025/5/27/ab75a654c6934572a4f1a566ac63ce82)
Comment (0)